Skip to main content
Log in

Effect of arginase on splenic killer cell activity in patients with gastric cancer

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Arginase has been detected in high levels in gastric cancer tissues. The effect of arginase on the activities of splenic natural killer (NK) cell, phytohemagglutinin activated killer (PAK) cell, and interleukin-2 activated killer (LAK) cell in patients with gastric cancer (N=12) was evaluatedin vitro. These activities in patients (N=10) with trauma and benign lesions were used as control. The splenic NK and PAK cell activities in patients with gastric cancer were significantly lower than in the controls (P<0.05), whereas LAK cell activity did not have significant difference. Arginase inhibited all splenic killer cell activities to a similar degree between patients with gastric cancer and the controls. The inhibition was dose-related. These data suggest that arginase may play a positive role in the spread of gastric cancer cells. However, LAK may be a potential approach of immunoadoptive therapy in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Su HL, Huang MH, Yu CL, Han SH, Chiang BN, Wang SR: Modulation of lymphocyte proliferation by murine liver extract. Asian Pac J Allergy Immunol 5:17–24, 1987

    PubMed  Google Scholar 

  2. Wu CW, Chi CW, Tsay SH, Lui WY, P'eng FK, Chang KL, Huang MH, Wang SR: The effect of arginase on neoplasm. I. The role of arginase in the immunosuppressive effects of extract from gastric cancer. Chin J Microbiol Immunol 20:279–289, 1987

    Google Scholar 

  3. Wu CW, Wang SR, Chang TJ, Lin EC, Chang KL, Huang MH, Lui WY, P'eng FK, Chi CW: Contents of glucocorticoid receptor and arginase in gastric cancer and normal gastric mucosal tissues. Cancer 64:2552–2556, 1989

    PubMed  Google Scholar 

  4. Lockwood CM: Immunological functions of the spleen. Clin Haematol 12:449–465, 1983

    PubMed  Google Scholar 

  5. Han T, Minowada J, Subramanian V, Barcos M, Kim U: Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease. Cancer 45:767–774, 1980

    PubMed  Google Scholar 

  6. Baroni CD, Ruco L, Uccini S, Foschi A, Occhionero M, Marcorelli E: Tissue T-lymphocytes in untreated Hodgkin's disease: Morphologic and functional correlations in spleens and lymph nodes. Cancer 50:259–268, 1982

    PubMed  Google Scholar 

  7. Akiyoshi T, Koba F, Arinaga S, Hideo T: Activated killer cell activity of spleen cells from patients with gastric carcinoma. J Clin Lab Immunol 23:197–201, 1987

    PubMed  Google Scholar 

  8. Health Statistics: National Health Administration, Republic of China, 1987

  9. Hebereer G, Teichmann RK, Kramling HJ, Gunther B: Results of gastric resection for carcinoma of the stomach: The European experience. World J Surg 12:374–381, 1988

    PubMed  Google Scholar 

  10. Greenberg PD: Tumor immunology.In Basic and Clinical Immunology, 6th ed. DP Stites, JD Stobo, JV Wells (eds). Los Altos, California, Lange Medical Publications, 1987, pp 186–196

    Google Scholar 

  11. Riccardi C, Barlozzari T, Santoni A, Herberman RB, Cesarini C: Transfer to cyclophosphamide-treated mice of natural killer (NK) cells andin vivo natural reactivity against tumors. J Immunol 126:1284–1289, 1981

    PubMed  Google Scholar 

  12. Hanna N, Fidler IJ: Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 65:801–809, 1980

    PubMed  Google Scholar 

  13. Mazumder A, Grimm EA, Zhang HZ, Rosenberg SA: Lysis of fresh human solid tumors by autologous lymphocytes activatedin vitro with lectins. Cancer Res 42:913–918, 1985

    Google Scholar 

  14. Mazumder A, Grimm EA, Rosenberg SA: Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization. Cancer Immunol Immunother 15:1–10, 1983

    PubMed  Google Scholar 

  15. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63, 1983

    PubMed  Google Scholar 

  16. Snedecor GW, Cochran WG: Statistical Methods. Ames, Iowa, Iowa State University Press, 1967

    Google Scholar 

  17. Riesenfeld I, Orn A, Gidlund M, Axberg I, Alm GV, Wigzell H: Positive correlation betweenin vitro NK activity andin vivo resistance towards AKR lymphoma cells. Int J Cancer 25:399–403, 1980

    PubMed  Google Scholar 

  18. Riccardi C, Barlozzari T, Santonia A, Herberman R, Cesarini C: Transfer to cyclophosphamide-treated mice of natural killer (NK) cells andin vivo natural reactivity against tumors. J Immunol 126:1284–1289, 1981

    PubMed  Google Scholar 

  19. Chu MH, Chien SC, Hu CP, Wang CY, Lee SD, Tsai YT, Wu JC, Han SH, Chang C: Natural and activated cytotoxic lymphocytes reactivity to human hepatocellular carcinoma cell lines in hepatocellular carcinoma patients. Liver 8:198–207, 1988

    PubMed  Google Scholar 

  20. Gerson JM: Systemic andin situ natural killer activity in tumor-bearing mice and patients with cancer.In Natural Cell-Mediated Immunity against Tumors. RB Herberman (ed). New York, Academic Press, 1980, pp 1047–1062

    Google Scholar 

  21. Karre K, Klein GO, Kiessling R, Klein G, Roder JC: Low naturalin vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature (London) 284:624–626, 1980

    PubMed  Google Scholar 

  22. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR: Role of NK cells in tumour growth and metastasis in beige mice. Nature (London) 284:622–624, 1980

    PubMed  Google Scholar 

  23. Habu S, Fukui H, Shimamura K, Kasai M, Nagai Y, Okumura K, Tamaoki N:In vivo effects of anti-asialo GM1 I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol 127:34–38, 1981

    PubMed  Google Scholar 

  24. Wu CW, Chi CW, Lin EC, Lui WY, P'eng FK, Wang SR: Serum arginase level in patients with gastric cancer. J Clin Gastroenterol 18:84–85, 1994

    PubMed  Google Scholar 

  25. Cheever MA, Greenberg PD, Alexander F: Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunizedin vivo andin vitro and nonspecifically expanded by culture with interleukin 2. J Immunol 126:1318–1322, 1981

    PubMed  Google Scholar 

  26. Rosenberg SA, Terry WD: Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma. Adv Cancer Res 25:323–388, 1977

    PubMed  Google Scholar 

  27. Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA:In vitro growth of cytotoxic human lymphocytes. IV. Lysis of fresh and cultured autologous tumor by lymphocytes cultured in T cell growth factor. Cancer Res 41:4420–4425, 1981

    PubMed  Google Scholar 

  28. Herberman RB, Hiserodt J, Vujanovic N, Balch C, Lotzova E, Bolhuis R, Golub S, Lanier LL, Phillips JH, Riccardi C, Ritz J, Santoni A, Schmidt RE, Uchida A: Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen. Immunol Today 8:178–181, 1987

    Google Scholar 

  29. Strausser JL, Mazumder A, Grimm EA, Lotze MT, Rosenberg SA: Lysis of human solid tumors by autologous cells sensitizedin vitro to alloantigens. J Immunol 127:266–271, 1981

    PubMed  Google Scholar 

  30. Grimm EA, Mazumder A, Zhang HA, Rosenberg SA: Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2-activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823–1841, 1982

    PubMed  Google Scholar 

  31. Watanabe T, Sakuma A: A clincopathological study on the upper gastric cancer with special reference to the choice of operative procedure. J Jpn Soc Surg 78:395–407, 1977

    Google Scholar 

  32. Orita K, Konaga E, Okada T, Kunissada K, Yumura M, Tanaka S: Effect of splenectomy in tumor bearing mice and gastric cancer patients. Gann 68:731–736, 1977

    PubMed  Google Scholar 

  33. Suehiro S, Nagasue N, Ogawa Y, Sasaki Y, Hirose S, Yukaya H: The negative effect of splenectomy on the prognosis of gastric cancer. Am J Surg 148:645–648, 1984

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported by a grant from National Science Council of the Republic of China (NSC 77-0412-B075-61).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, CW., Chi, CW., Ho, CK. et al. Effect of arginase on splenic killer cell activity in patients with gastric cancer. Digest Dis Sci 39, 1107–1112 (1994). https://doi.org/10.1007/BF02087565

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087565

Key words

Navigation